Cholinergic treatments for Alzheimer's disease.
Roberts
F
F
Department of Neuropharmacology, Glaxo Group Research, Ware, Herts., U.K.
Lazareno
S
S
D000544:Alzheimer Disease / Q000188:drug therapy*; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000502:physiology; D004195:Disease Models, Animal; D006801:Humans; D010277:Parasympathomimetics / Q000627:therapeutic use*
D010277:Parasympathomimetics